Complexo Hospitalario Universitario de Santiago
Centro de atención
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublicacións en colaboración con investigadores/as de AstraZeneca (United Kingdom) (27)
2024
-
Airway and Blood Monocyte Transcriptomic Profiling Reveals an Antiviral Phenotype in Infants With Severe Respiratory Syncytial Virus Infection
Journal of Infectious Diseases, Vol. 229, pp. S100-S111
-
The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus
Nature communications, Vol. 15, Núm. 1, pp. 3083
2023
-
Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data
The Lancet Infectious Diseases, Vol. 23, Núm. 7, pp. 856-866
-
Portuguese Heart Failure Prevalence Observational Study (PORTHOS) rationale and design – A population-based study
Revista Portuguesa de Cardiologia, Vol. 42, Núm. 12, pp. 985-995
2022
-
Age-Specific Estimates of Respiratory Syncytial Virus-Associated Hospitalizations in 6 European Countries: A Time Series Analysis
Journal of Infectious Diseases, Vol. 226, pp. S29-S37
-
Global Disease Burden of Respiratory Syncytial Virus in Preterm Children in 2019: A Systematic Review and Individual Participant Data Meta-Analysis Protocol
Journal of Infectious Diseases, Vol. 226, pp. S135-S141
-
Patient Involvement in RSV Research: Towards Patients Setting the Research Agenda
Journal of Infectious Diseases, Vol. 226, pp. S130-S134
-
Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials
Journal of Clinical Epidemiology, Vol. 147, pp. 11-20
2021
-
Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus
Nature Communications, Vol. 12, Núm. 1
-
Effects of dapagliflozin on mortality in patients with chronic kidney disease: A pre-specified analysis from the DAPA-CKD randomized controlled trial
European Heart Journal, Vol. 42, Núm. 13, pp. 1216-1227
-
Global and regional burden of hospital admissions for pneumonia in older adults: A systematic review and meta-analysis
Journal of Infectious Diseases, Vol. 222, pp. S570-S576
-
Immunological and inflammatory biomarkers of susceptibility and severity in adult respiratory syncytial virus infections
Journal of Infectious Diseases, Vol. 222, pp. S584-S591
-
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
The Lancet Respiratory Medicine, Vol. 9, Núm. 3, pp. 260-274
-
Publisher Correction: Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus (Nature Communications, (2021), 12, 1, (5125), 10.1038/s41467-021-25265-4)
Nature Communications
2020
-
Global molecular diversity of RSV - The "iNFORM RSV" study
BMC Infectious Diseases, Vol. 20, Núm. 1
-
The solid progress of nanomedicine
Drug Delivery and Translational Research, Vol. 10, Núm. 3, pp. 726-729
2019
-
Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine
American Journal of Cardiovascular Drugs, Vol. 19, Núm. 2, pp. 173-183
-
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
The Lancet, Vol. 394, Núm. 10204, pp. 1169-1180
2016
-
Cost-effectiveness analysis of the direct and indirect impact of intranasal live attenuated influenza vaccination strategies in children: alternative country profiles
Journal of Market Access and Health Policy, Vol. 4, Núm. 1
-
EGFR testing and clinical management of advanced NSCLC: A galician lung cancer group study (GGCP 048-10)
Cancer Management and Research, Vol. 8, pp. 11-20